Ellevest Inc’s GenMark Diagnostics, Inc GNMK Stock Holding History

Ellevest Inc’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	–	–	1430
2020 Q3	$0	Buy	+2	New	+$31	﹤0.01%	1387

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ellevest Inc's GNMK Position: Q4 2020 in Review

Ellevest Inc sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 2 shares.

Ellevest Inc first reported a position in GNMK in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

Ellevest Inc reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
Ellevest Inc sold 2 GenMark Diagnostics, Inc shares in Q4 2020.
Ellevest Inc first reported a position in GenMark Diagnostics, Inc in Q3 2020 and held it in 1 quarter.
Ellevest Inc's GenMark Diagnostics, Inc position peaked at $0 in Q3 2020.
151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.